CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 48 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 4.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,360,020 | -68.1% | 210,204 | -69.4% | 0.02% | -68.0% |
| Q2 2023 | $4,257,253 | +50.2% | 687,763 | -6.6% | 0.05% | +28.2% |
| Q1 2023 | $2,833,573 | +316.6% | 735,993 | +235.4% | 0.04% | +333.3% |
| Q4 2022 | $680,202 | -5.3% | 219,420 | +22.9% | 0.01% | -10.0% |
| Q3 2022 | $718,000 | -88.8% | 178,568 | -86.4% | 0.01% | -89.9% |
| Q2 2022 | $6,402,000 | -19.1% | 1,314,652 | +48.9% | 0.10% | -23.3% |
| Q1 2022 | $7,917,000 | -12.2% | 882,633 | +10.2% | 0.13% | 0.0% |
| Q4 2021 | $9,021,000 | -38.8% | 801,136 | -9.3% | 0.13% | -46.5% |
| Q3 2021 | $14,743,000 | -19.3% | 882,813 | +7.3% | 0.24% | -29.3% |
| Q2 2021 | $18,268,000 | – | 822,518 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,937,615 | $19,006,369 | 42.74% |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $129,161,626 | 41.24% |
| Vida Ventures Advisors, LLC | 3,931,818 | $25,438,862 | 39.38% |
| TCG Crossover Management, LLC | 2,040,816 | $13,204,079 | 1.94% |
| Affinity Asset Advisors, LLC | 1,018,091 | $6,587,049 | 1.85% |
| BVF INC/IL | 9,103,054 | $58,896,759 | 1.59% |
| Sio Capital Management, LLC | 756,891 | $4,897,085 | 1.52% |
| ACUTA CAPITAL PARTNERS, LLC | 323,349 | $2,092,068 | 1.40% |
| EcoR1 Capital, LLC | 5,618,779 | $36,353,500 | 1.23% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $62,641,362 | 0.97% |